Glycolysis inhibition for anticancer treatment

Hélène Pelicano(The University of Texas MD Anderson Cancer Center), Daniel Martín(Memorial Sloan Kettering Cancer Center), Rui‐Hua Xu(Sun Yat-sen University Cancer Center), Ping Huang(Center for Translational Molecular Medicine)
Oncogene
August 7, 2006
10.1038/sj.onc.1209597
Cited by 1,512

Abstract

Related Papers

THE METABOLISM OF TUMORS
OTTO WARBURN, F. Dickens|The American Journal of the Medical Sciences|1931|814
Soybean Phytochemicals Inhibit the Growth of Transplantable Human Prostate Carcinoma and Tumor Angiogenesis in Mice
Jin‐Rong Zhou, Eric T. Gugger, Toshihide Tanaka et al.|Journal of Nutrition|1999|344
ENO1 gene product binds to the c‐<i>myc</i> promoter and acts as a transcriptional repressor: relationship with Myc promoter‐binding protein 1 (MBP‐1)
Salvatore Feo, Daniela Arcuri, Eugenia Piddini et al.|FEBS Letters|2000|271
Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase
Saroj P. Mathupala, Annette Rempel, Peter L. Pedersen|Journal of Bioenergetics and Biomembranes|1997|247
The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae
Aránzazu RODRÍGUEZ, Tamara de la, Pilar Herrero et al.|Biochemical Journal|2001|215